Session Name: Concurrent Session: PTLD/Malignancies: All Topics
Session Type: Concurrent Session
Date: Monday, June 4, 2018
Session Time: 2:30pm-4:00pm
Presentation Time: 2:30pm-2:42pm
Location: Room 4C-4
Purpose: The inherent challenges of selecting an acceptable donor for each of the increasing numbers and acuity of recipients has led programs to take increased risks. The outcomes of organ transplantation using organs from DWCH remained to be clarified. We aimed to make an assessment of transplant outcomes of recipients using organs from DWCH.
Methods: Retrospective analysis of the Scientific Registry of Transplant Recipients data from January 1st, 2000 to December 31th, 2014, identified 8385 cases of transplants from DWCH. Survival analysis with risk variables adjustment were compared in recipients from donors with versus without cancer history. A Cox-proportional hazard regression model and the log-rank test were used to compare the survival, hazard level of various types of cancer.
Results: The number of DWCH was growing. Results showed that DWCH was an independent risk factor of 5-year patient survival (HR=1.089, 95% CI: 1.009-1.176, P=0.03) and graft survival (HR=1.129, 95% CI: 1.056-1.208, P<0.01) in liver transplantation and heart transplantation (patient survival: HR=1.112, 95% CI: 1.057-1.170, P<0.01; graft survival: HR=1.244, 95% CI: 1.052-1.472, P=0.01). There was no remarkable difference between two groups in kidney and lung transplantation. The adjusted cumulative probability of malignancy showed no difference in kidney, liver, heart and lung transplantation. Donors with genitourinary and gastrointestinal cancers were related to inferior outcomes in kidney transplantation. Donors with central nervous system cancer resulted in poorer survival in liver transplant recipients. Recipients from donors with hematologic malignancy and otorhinolaryngologic cancer had a poorer survival in heart transplantation.
Conclusion: Under the current donor selection criteria, recipients from DWCH had inferior outcomes in liver and heart transplantation. Specific cancer types should be evaluated before applying to distinct organ transplantation.
CITATION INFORMATION: Guo Z., He X., Huang S. Outcomes of Organ Transplantation from Donors with Cancer History Am J Transplant. 2017;17 (suppl 3).
To cite this abstract in AMA style:Guo Z, He X, Huang S. Outcomes of Organ Transplantation from Donors with Cancer History [abstract]. https://atcmeetingabstracts.com/abstract/outcomes-of-organ-transplantation-from-donors-with-cancer-history/. Accessed September 22, 2023.
« Back to 2018 American Transplant Congress